SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-06-215703
Filing Date
2006-10-26
Accepted
2006-10-26 14:02:16
Documents
5
Period of Report
2006-11-30
Effectiveness Date
2006-10-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 741328
2 GRAPHIC g98781g12c39.jpg GRAPHIC 9412
3 GRAPHIC g98781g81z99.jpg GRAPHIC 65723
4 GRAPHIC g98781g88d11.jpg GRAPHIC 10359
5 GRAPHIC g98781g97z57.jpg GRAPHIC 7065
  Complete submission text file 0001193125-06-215703.txt   870895
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12465 | Film No.: 061165308
SIC: 2834 Pharmaceutical Preparations